Breast Biopsy Devices Market Trend and Forecast To 2027, Key Player - Hologic Inc., Medtronic PLC.

Industryno102 Dec, 2021Business

North America dominates the breast biopsy devices market owing to the rising cases of breast cancer, growing geriatric population, increased expenditure on healthcare, economic prosperity, and expansion of private healthcare sector. Hologic has received the European CE mark for Breva Breast Biopsy System with CorLumina Imaging Technology. The system is designed to improve biopsy accuracy, improve patient satisfaction, and streamline the biopsy suite workflow through real-time imaging.